BioCentury | Sep 16, 2016
Politics & Policy

NCI releases data tool for clinical trial searches

...develop the interface as part of the Cancer Moonshot Initiative. NCI said precision medicine companies Cure Forward Corp....
BioCentury | Aug 3, 2015
Company News

Paradigm, Cure Forward deal

...to their disease. Results from Paradigm’s next-generation sequencing (NGS)-based PCDx test will be integrated into Cure Forward’s...
...disease profiles. The companies did not disclose financial details. Paradigm Inc. , Ann Arbor, Mich. Cure Forward Corp....
BioCentury | Jun 20, 2015
Financial News

Cure Forward raises $15M in series A round

Cure Forward (Cambridge, Mass.) raised $15 million in a series A round. Apple Tree Partners was the sole investor. The company expects to launch a technology platform in September that is designed to connect cancer...
Items per page:
1 - 3 of 3
BioCentury | Sep 16, 2016
Politics & Policy

NCI releases data tool for clinical trial searches

...develop the interface as part of the Cancer Moonshot Initiative. NCI said precision medicine companies Cure Forward Corp....
BioCentury | Aug 3, 2015
Company News

Paradigm, Cure Forward deal

...to their disease. Results from Paradigm’s next-generation sequencing (NGS)-based PCDx test will be integrated into Cure Forward’s...
...disease profiles. The companies did not disclose financial details. Paradigm Inc. , Ann Arbor, Mich. Cure Forward Corp....
BioCentury | Jun 20, 2015
Financial News

Cure Forward raises $15M in series A round

Cure Forward (Cambridge, Mass.) raised $15 million in a series A round. Apple Tree Partners was the sole investor. The company expects to launch a technology platform in September that is designed to connect cancer...
Items per page:
1 - 3 of 3